Export

Eurofins Biopharma Product Testing Sweden AB

Financial information

The information source is the annual report of the company with business id 556225-2196

* Closing information (×1000) SEK

Fiscal year 202212 202112
Number of months: 12 12
Turnover: 61,765 Revenue Up 56,116 Revenue Down
Financial expenses: 1,675 Revenue Up 1,157 Revenue Up
Earnings before taxes: -21,022 Revenue Up -23,168 Revenue Down
Total assets: 46,159 Revenue Down 61,324 Revenue Up
Current assets: 26,015 Revenue Down 42,209 Revenue Up
Current liabilities: 13,888 Revenue Down 13,937 Revenue Up
Equity capital: 1,668 Revenue Down 18,560 Revenue Up
Share capital: 100 100
Number of employees: 50 Revenue Down 60 Revenue Up

Financial ratios

Solvency: 3.6% Revenue Down 30.3% Revenue Up
Turnover per employee: 1,235 Revenue Up 935 Revenue Down
Profitability: -34.0% Revenue Up -41.3% Revenue Down
Return on equity (ROE): -1.260.3% Revenue Down -124.8% Revenue Down
Current ratio: 187.3% Revenue Down 302.9% Revenue Up
Return on assets (ROA): -41.9% Revenue Down -35.9% Revenue Down

Companies with similar products and services, and with detailed information

Fiscal year 202212
Number of months: 12
Turnover: 61,765
Financial expenses: 1,675
Earnings before taxes: -21,022
Total assets: 46,159
Current assets: 26,015
Current liabilities: 13,888
Equity capital: 1,668
Share capital: 100
Number of employees: 50

Financial ratios

Solvency: 3.6%
Turnover per employee: 1,235
Profitability: -34.0%
Return on equity (ROE): -1.260.3%
Current ratio: 187.3%
Return on assets (ROA): -41.9%